{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:49:13Z","timestamp":1760345353129},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several studies on pregnancy complications of poor ovarian response (POR) patients did not draw a consistent conclusion. The POSEIDON criteria introduces the concept of \u201clow prognosis\u201d and divides POR patients into four groups based on age, AFC and AMH for individualized management. We analyzed low-prognosis population and patients with regular ovarian response, compared maternal and neonatal complications and discussed the relevant risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted of females who achieved a singleton clinical pregnancy after IVF \/ ICSI\u2014fresh embryo transfer in a single center from January 2014 to March 2019. Participants with low prognosis, as defined by the POSEIDON criteria, were enrolled in the study groups. The controls were defined as AFC\u2009\u2265\u2009five and number of retrieved oocytes\u2009&gt;\u2009nine. Maternal and neonatal complications were compared among those groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 2554 cycles in POSEIDON group 1, 971 in POSEIDON group 2, 141 in POSEIDON group 3, 142 in POSEIDON group 4, and 3820 in Control. Univariate analysis roughly showed that Groups 2 and 4 had an increased tendency of pregnancy complications. Multi-variable generalized estimating equations (GEE) analysis showed that the risks of GDM, total pregnancy loss, and first-trimester pregnancy loss in Groups 2 and 4 were significantly higher than in Control. The risk of hypertensive disorders of pregnancy (HDP) in Groups 2 and 3 increased, and Group 4 had an increased tendency without statistical significance. After classification by age, GEE analysis showed no significant difference in risks of all complications among groups\u2009\u2265\u200935\u00a0years. In patients\u2009&lt;\u200935\u00a0years, the risk of HDP in POSEIDON group 3 was significantly higher than in controls (&lt;\u200935\u00a0years), and there was no significant increase in the risk of other complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Compared to patients with regular ovarian response, low-prognosis population have increased tendency of maternal and neonatal complications. In low-prognosis patients, advanced age (\u2265\u200935\u00a0years) might be the predominant risk factor for pregnancy complications. In those\u2009&lt;\u200935\u00a0years, poor ovarian reserve could contribute to HDP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-06176-2","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T07:04:07Z","timestamp":1702364647000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maternal and neonatal complications after IVF\/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Shiguang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"6176_CR1","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324.","journal-title":"Hum Reprod"},{"key":"6176_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P, Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number). A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105:1452\u20133.","journal-title":"Fertil Steril"},{"key":"6176_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3389\/fendo.2019.00679","volume":"10","author":"NP Polyzos","year":"2019","unstructured":"Polyzos NP, Drakopoulos P. Management Strategies for POSEIDON\u2019s Group 1. Front Endocrinol (Lausanne). 2019;10:679.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fendo.2020.00105","volume":"11","author":"SK Sunkara","year":"2020","unstructured":"Sunkara SK, Ramaraju GA, Kamath MS. Management Strategies for POSEIDON Group 2. Front Endocrinol (Lausanne). 2020;11:105.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fendo.2019.00614","volume":"10","author":"T Haahr","year":"2019","unstructured":"Haahr T, Dosouto C, Alviggi C, Esteves SC, Humaidan P. Management Strategies for POSEIDON Groups 3 and 4. Front Endocrinol (Lausanne). 2019;10:614.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3389\/fendo.2019.00642","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Li X, Yang X, Cai S, Lu G, Lin G, Humaidan P, Gong F. Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization\/Intracytoplasmic Sperm Injection. Front Endocrinol (Lausanne). 2019;10:642.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fendo.2019.00409","volume":"10","author":"W Shi","year":"2019","unstructured":"Shi W, Zhou H, Tian L, Zhao Z, Zhang W, Shi J. Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles. Front Endocrinol (Lausanne). 2019;10:409.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.rbmo.2020.08.003","volume":"41","author":"R Yang","year":"2020","unstructured":"Yang R, Zhang C, Chen L, Wang Y, Li R, Liu P, Qiao J. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis. Reprod Biomed Online. 2020;41:834\u201344.","journal-title":"Reprod Biomed Online"},{"key":"6176_CR9","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/humrep\/del155","volume":"21","author":"GH Woldringh","year":"2006","unstructured":"Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF\/ICSI pregnancies. Hum Reprod. 2006;21:2948\u201354.","journal-title":"Hum Reprod"},{"key":"6176_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.fertnstert.2009.01.092","volume":"93","author":"J van Disseldorp","year":"2010","unstructured":"van Disseldorp J, Eijkemans R, Fauser B, Broekmans F. Hypertensive pregnancy complications in poor and normal responders after in vitro fertilization. Fertil Steril. 2010;93:652\u20137.","journal-title":"Fertil Steril"},{"key":"6176_CR11","first-page":"1","volume":"2","author":"HA Parlakg\u00fcm\u00fc\u015f","year":"2011","unstructured":"Parlakg\u00fcm\u00fc\u015f HA, Haydardedeo\u011flu B, Sim\u015fek E, Cok T, Yal\u00e7\u0131nkaya C, Iskender C, K\u0131l\u0131\u00e7da\u011f EB. Are pregnancy complications increased in poor responders? J Turk Ger Gynecol Assoc. 2011;2:1\u20133.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"6176_CR12","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1038\/s41598-020-68896-1","volume":"10","author":"RK Abdullah","year":"2020","unstructured":"Abdullah RK, Liu N, Zhao Y, Shuang Y, Shen Z, Zeng H, Wu J. Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF\/ICSI cycles: a single-center retrospective study. Sci Rep. 2020;10:11822.","journal-title":"Sci Rep"},{"key":"6176_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"6176_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/oxfordjournals.humrep.a136618","volume":"2","author":"F Puissant","year":"1987","unstructured":"Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod. 1987;2:705\u20138.","journal-title":"Hum Reprod"},{"key":"6176_CR15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155\u20138.","journal-title":"Fertil Steril"},{"key":"6176_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/humrep\/deg047","volume":"18","author":"T Mukaida","year":"2003","unstructured":"Mukaida T, Nakamura S, Tomiyama T, Wada S, Oka C, Kasai M, Takahashi K. Vitrification of human blastocysts using cryoloops: clinical outcome of 223 cycles. Hum Reprod. 2003;18:384\u201391.","journal-title":"Hum Reprod"},{"key":"6176_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","volume":"4","author":"AL Tranquilli","year":"2014","unstructured":"Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97\u2013104.","journal-title":"Pregnancy Hypertens"},{"key":"6176_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.diabres.2013.10.012","volume":"103","author":"World health organization","year":"2014","unstructured":"World health organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103:341\u201363.","journal-title":"Diabetes Res Clin Pract"},{"key":"6176_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/humupd\/dmv041","volume":"22","author":"S Giakoumelou","year":"2016","unstructured":"Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22:116\u201333.","journal-title":"Hum Reprod Update"},{"key":"6176_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1471-0528.15628","volume":"126","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D, Kayem G, Kingdom J, Silver R, Sentilhes L, Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No 27a. BJOG. 2019;126:e1\u201348.","journal-title":"BJOG"},{"key":"6176_CR21","doi-asserted-by":"crossref","unstructured":"Macrosomia: ACOG Practice Bulletin, Number 216. Obstet Gynecol. 2020;135:e18-e35.","DOI":"10.1097\/AOG.0000000000003606"},{"key":"6176_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.fertnstert.2015.02.009","volume":"103","author":"E Evron","year":"2015","unstructured":"Evron E, Sheiner E, Friger M, Sergienko R, Harlev A. Vanishing twin syndrome: is it associated with adverse perinatal outcome? Fertil Steril. 2015;103:1209\u201314.","journal-title":"Fertil Steril"},{"key":"6176_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.metabol.2017.11.011","volume":"86","author":"C Antza","year":"2018","unstructured":"Antza C, Cifkova R, Kotsis V. Hypertensive complications of pregnancy: A clinical overview. Metabolism. 2018;86:102\u201311.","journal-title":"Metabolism"},{"key":"6176_CR24","doi-asserted-by":"publisher","first-page":"H387","DOI":"10.1152\/ajpheart.00045.2019","volume":"317","author":"CM Cooke","year":"2019","unstructured":"Cooke CM, Davidge ST. Advanced maternal age and the impact on maternal and offspring cardiovascular health. Am J Physiol Heart Circ Physiol. 2019;317:H387\u201394.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6176_CR25","doi-asserted-by":"publisher","first-page":"648287","DOI":"10.3389\/fendo.2021.648287","volume":"12","author":"S Han","year":"2021","unstructured":"Han S, Zhai Y, Guo Q, Qin Y, Liu P. Maternal and Neonatal Complications in Patients With Diminished Ovarian Reserve in In-Vitro Fertilization\/Intracytoplasmic Sperm Injection Cycles. Front Endocrinol (Lausanne). 2021;12:648287.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6176_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/gme.0b013e31815982cf","volume":"15","author":"JE Mersereau","year":"2008","unstructured":"Mersereau JE, Evans ML, Moore DH, Liu JH, Thomas MA, Rebar RW, Pennington E, Cedars MI. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women. Menopause. 2008;15:482\u20136.","journal-title":"Menopause"},{"key":"6176_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.118.12046","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck F, Narasimhan P, Selamet Tierney ES, Martinez N, Conrad KP, Baker VL, Winn VD. Absent or Excessive Corpus Luteum Number Is Associated With Altered Maternal Vascular Health in Early Pregnancy. Hypertension. 2019;73:680\u201390.","journal-title":"Hypertension"},{"key":"6176_CR28","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/humrep\/deaa235","volume":"35","author":"PI Cavoretto","year":"2020","unstructured":"Cavoretto PI, Farina A, Miglio R, Zamagni G, Girardelli S, Vanni VS, Morano D, Spinillo S, Sartor F, Candiani M. Prospective longitudinal cohort study of uterine arteries Doppler in singleton pregnancies obtained by IVF\/ICSI with oocyte donation or natural conception. Hum Reprod. 2020;35:2428\u201338.","journal-title":"Hum Reprod"},{"key":"6176_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0921-8734(95)90004-7","volume":"316","author":"J Remacle","year":"1995","unstructured":"Remacle J, Raes M, Toussaint O, Renard P, Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutat Res. 1995;316:103\u201322.","journal-title":"Mutat Res"},{"key":"6176_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cjca.2015.02.008","volume":"31","author":"AC Montezano","year":"2015","unstructured":"Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol. 2015;31:631\u201341.","journal-title":"Can J Cardiol"},{"key":"6176_CR31","doi-asserted-by":"publisher","first-page":"H1417","DOI":"10.1152\/ajpheart.00089.2013","volume":"305","author":"SI Dikalov","year":"2013","unstructured":"Dikalov SI, Ungvari Z. Role of mitochondrial oxidative stress in hypertension. Am J Physiol Heart Circ Physiol. 2013;305:H1417\u201327.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6176_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5:47.","journal-title":"Nat Rev Dis Primers"},{"key":"6176_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","volume":"6","author":"E Dimitriadis","year":"2020","unstructured":"Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6:98.","journal-title":"Nat Rev Dis Primers"},{"key":"6176_CR34","doi-asserted-by":"publisher","first-page":"108320","DOI":"10.1016\/j.mrrev.2020.108320","volume":"785","author":"M Mikwar","year":"2020","unstructured":"Mikwar M, MacFarlane AJ, Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat Res Rev Mutat Res. 2020;785:108320.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"6176_CR35","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Gynecology","year":"2018","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018;132:e197\u2013207.","journal-title":"Obstet Gynecol."},{"key":"6176_CR36","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","volume":"75","author":"VD Garovic","year":"2020","unstructured":"Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, Weissgerber TL, Milic N, Weaver A, Mielke MM. Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy. J Am Coll Cardiol. 2020;75:2323\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"6176_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.fertnstert.2020.02.112","volume":"114","author":"S Hu","year":"2020","unstructured":"Hu S, Xu B, Jin L. Perinatal outcome in young patients with diminished ovarian reserve undergoing assisted reproductive technology. Fertil Steril. 2020;114:118\u201324.","journal-title":"Fertil Steril"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-06176-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06176-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T19:02:28Z","timestamp":1702407748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-06176-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6176"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-06176-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki (as revised in 2013) and approved by the Institutional Review Board of the Center for Reproductive Medicine, Shandong University. (96990) Informed consent was waived by the Institutional Review Board for this study due to its retrospective nature and the use of an anonymous database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"855"}}